Cannabis stocks face Massachusetts rollback risk, Insight Guru says

Massachusetts votes Tuesday on ending recreational cannabis sales, threatening an adult-use market worth about $1.65 billion annually. * Curaleaf is the most exposed operator covered by the analysis; medical cannabis sales would remain legal. * Federal rescheduling offers the biggest potential profit boost for U.S. operators by ending the 280E tax restriction on normal business deductions. * The DEA controls the rescheduling decision, not Congress; no deadline is set. * A Democratic congressional victory would not guarantee SAFE Banking legislation, which has never reached a Senate floor vote. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Insight Guru Inc. published the original content used to generate this news brief on November 03, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

MSOX